Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1993 May;69(5):391–394. doi: 10.1136/hrt.69.5.391

Anticardiolipin antibodies in ischaemic heart disease: marker or myth?

K V Phadke 1, R A Phillips 1, D T Clarke 1, M Jones 1, P Naish 1, P Carson 1
PMCID: PMC1025099  PMID: 8518060

Abstract

OBJECTIVES--To assess the incidence and significance of anticardiolipin antibodies after myocardial infarction and in unstable angina. DESIGN--A prospective study of all patients under 60 admitted to the coronary care unit over a 12 month period with a diagnosis of acute myocardial infarction who were followed up for a further 12 months. Patients admitted with unstable angina were similarly assessed but not followed up. Anticardiolipin antibody concentrations were compared with those of age matched controls. SETTING--A district general hospital. PATIENTS--307 patients with acute myocardial infarction and 160 patients with unstable angina. RESULTS--Anticardiolipin antibody concentrations in the two patient groups did not differ significantly from those in the control groups. Antibody concentrations were not related to a history of angina or myocardial infarction nor were they related to subsequent cardiovascular complications. CONCLUSION--This study shows no significant association between anticardiolipin antibody concentrations and either myocardial infarction or unstable angina.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Mackay I. R., Harris E. N. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. Br Heart J. 1986 Aug;56(2):190–193. doi: 10.1136/hrt.56.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hamsten A., Norberg R., Björkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986 Jan 18;1(8473):113–116. doi: 10.1016/s0140-6736(86)92258-0. [DOI] [PubMed] [Google Scholar]
  3. Harris E. N., Asherson R. A., Hughes G. R. Antiphospholipid antibodies--autoantibodies with a difference. Annu Rev Med. 1988;39:261–271. doi: 10.1146/annurev.me.39.020188.001401. [DOI] [PubMed] [Google Scholar]
  4. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. [PMC free article] [PubMed] [Google Scholar]
  5. Harris E. N., Gharavi A. E., Patel S. P., Hughes G. R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987 Apr;68(1):215–222. [PMC free article] [PubMed] [Google Scholar]
  6. Harris E. N., Hughes G. R. Standardising the anti-cardiolipin antibody test. Lancet. 1987 Jan 31;1(8527):277–277. doi: 10.1016/s0140-6736(87)90099-7. [DOI] [PubMed] [Google Scholar]
  7. Harris E. N., Hughes G. R. Standardising the anti-cardiolipin antibody test. Lancet. 1987 Jan 31;1(8527):277–277. doi: 10.1016/s0140-6736(87)90099-7. [DOI] [PubMed] [Google Scholar]
  8. Klemp P., Cooper R. C., Strauss F. J., Jordaan E. R., Przybojewski J. Z., Nel N. Anti-cardiolipin antibodies in ischaemic heart disease. Clin Exp Immunol. 1988 Nov;74(2):254–257. [PMC free article] [PubMed] [Google Scholar]
  9. Loizou S., McCrea J. D., Rudge A. C., Reynolds R., Boyle C. C., Harris E. N. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol. 1985 Dec;62(3):738–745. [PMC free article] [PubMed] [Google Scholar]
  10. Meroni P. L., Harris E. N., Brucato A., Tincani A., Barcellini W., Vismara A., Balestrieri G., Hughes G. R., Zanussi C. Anti-mitochondrial type M5 and anti-cardiolipin antibodies in autoimmune disorders: studies on their association and cross-reactivity. Clin Exp Immunol. 1987 Mar;67(3):484–491. [PMC free article] [PubMed] [Google Scholar]
  11. Morton K. E., Gavaghan T. P., Krilis S. A., Daggard G. E., Baron D. W., Hickie J. B., Chesterman C. N. Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet. 1986 Dec 13;2(8520):1353–1357. doi: 10.1016/s0140-6736(86)92004-0. [DOI] [PubMed] [Google Scholar]
  12. Sletnes K. E., Smith P., Abdelnoor M., Arnesen H., Wisløff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet. 1992 Feb 22;339(8791):451–453. doi: 10.1016/0140-6736(92)91057-f. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES